Mounjaro week 3 side effects: deciding what's normal and what needs attention

The symptoms most people notice at this point

Week three tends to be the period where early Mounjaro side effects either start to settle or feel most established before they do. The gut is still adapting to tirzepatide's dual mechanism (slowed stomach emptying combined with changes in appetite signalling) and that adaptation isn't always comfortable.

Nausea is the most frequently reported early symptom. It tends to be worst in the hours after injection and often improves within a day or two as the dose level in your system stabilises. Loose stools, constipation, bloating and indigestion are all common alongside it, and some people notice burping or an unpleasant taste. Fatigue and mild headache appear less often but are recognised effects at this stage too.

The experience in week one can differ from week three in one important way: by now you may have had two or three injections, and for some people each one brings a brief renewal of symptoms that then fades. This is a known pattern, not a sign something has gone wrong. Eating smaller meals, staying well hydrated, and avoiding rich or fatty food on injection day are practical steps that many people find reduce the severity.

Injection-site reactions (redness, mild bruising, or a little soreness) are also possible at week three and are generally minor. Rotating the injection site between your abdomen, thigh, and upper arm helps.

The decision in front of you: carry on, adjust, or seek help?

This is where a lot of people find themselves at week three, and it's a fair place to feel uncertain. Side effects that are unpleasant but manageable, improving between doses, and not affecting your ability to eat and drink are typically part of the adjustment period. Symptoms that are worsening, making it hard to keep fluids down, or that feel disproportionately severe are a different matter entirely.

Dehydration is a real risk if vomiting or diarrhoea is sustained. If you cannot keep fluids down for more than a day, or you feel dizzy and unwell beyond what you'd associate with nausea alone, contact a healthcare professional rather than waiting it out. You can review what the broader side-effect picture looks like across the full treatment course to understand how this early phase fits in.

Some people at week three are also wondering whether their symptoms are worse than average, and it can help to know which five Mounjaro side effects come up most often so you have a clearer sense of what is typical. The SURMOUNT-1 trial, which examined tirzepatide in thousands of adults with obesity over 72 weeks and is summarised in the original NEJM publication, found that most gastrointestinal effects were mild to moderate in severity and were concentrated in the early titration phase. Serious adverse effects were uncommon. That doesn't make a difficult week three feel trivial, but it does provide some context.

If your symptoms feel difficult to manage, speaking to your prescriber about the pace of titration or practical coping strategies is entirely appropriate. A message to our team takes a few minutes.

When to get medical help without delay

Most week-three symptoms do not need emergency attention. A few do.

Seek urgent care if you develop severe pain in your abdomen that doesn't ease and radiates towards your back, with or without vomiting. This is a recognised warning symptom for acute pancreatitis, an infrequent but serious complication flagged specifically by the MHRA in January 2026 for GLP-1 medicines including tirzepatide. Do not wait to see if it passes.

Other situations that need prompt medical review: signs of an allergic reaction (swelling of the face, lips or throat, difficulty breathing, a widespread rash); symptoms suggesting significant dehydration (very dark urine, dizziness on standing, inability to keep any fluids down); and any sudden changes in vision, which in people with diabetes may indicate a retinopathy-related issue.

If you think you may have been supplied with a counterfeit pen (for instance if you sourced it outside a GPhC-registered pharmacy and notice something unusual about the device or its contents) report it to the MHRA Yellow Card scheme and seek medical advice. Fake pens have caused serious harm in documented cases. You can verify any online pharmacy on the GPhC register.

What comes next and how our prescribers support you through it

For most people, the side-effect picture at week four and beyond looks noticeably better than week three. The first titration step, if your prescriber moves you to 5mg, brings another short adjustment period, you can read about what that phase typically involves on the week-two side effects page for comparison, since the pattern has similarities.

At nume, every repeat order is clinically re-reviewed before it is dispensed. That review is carried out by a GPhC-registered Independent Prescriber reading your case, not an automated system. If you've had a difficult few days and want to discuss it before your next dose, our consultation process is the starting point, and aftercare support is available seven days a week.

Understanding what Mounjaro is doing in your body during this early phase can also help frame the experience, and many people find it useful to read about what to expect specifically on day three after an injection alongside our Mounjaro overview, which covers the mechanism in more detail. Side effects are real. So is the fact that the majority of people move through them.